CrushSCI.com
Journal Selection & Manuscript Polishing Services
ACTA PHARMACOLOGICA SINICA journal cover Medicine
Back to journal directory

Review Cycle Records

ACTA PHARMACOLOGICA SINICA

Springer SCIE Non-OA
2026 Emerging Zone 12025 CAS Zone 22025 JCR Q1
141.9Average days
129Median days
66Fastest days
235Longest days
2562025 publications

Paper Review Records

All Paper Review Records

20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

96 days

TGF-β2 signaling promotes cardiac fibrosis in arrhythmogenic right ventricular cardiomyopathy mediated by DSC2 deficiency

AuthorsChen-xing Huang; Ke-jia Jin; Lan-qing Xiang; Zhuo-xin Lv; Ying Wang; Jian-guo Jia; Fei-zhen Wu; Yi-zhun Zhu; Yun-zeng Zou; Yu-xiang Dai; Hui Gong

Affiliations1. Shanghai Institute of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Diseases, Zhongshan Hospital and Institutes of Biomedical Sciences, NHC Key Laboratory of Ischemic Heart Diseases, Key Laboratory of Viral Heart Diseases, Chinese Academy of Medical Sciences, Fudan University, Shanghai, China; 2. State Key Laboratory of Quality Research in Chinese Medicine and School of Pharmacy, Macau University of Science and Technology, Macao, China

Source PDF DOI Publisher page
161 days

S1UTRSP5, a short restructured RNA from SLIT1 3′UTR, mitigates mouse cardiac remodeling via enhancing SlRT1 activity

AuthorsJin-feng Su; Tao Ou; Xiao-yao Liu; Xue-min Su; Ya Wang; Yi-hong Wen; Yuan Gao; Ruo-han Li; Lu-fang Huang; Chuan-meng Zhou; Heng-li Zhao; Jie-ning Zhu; Ning Ma; Xi-long Zheng; Yu-peng Liu; Jin-dong Xu; Hui Li; Xian-hong Fang; Zhi-xin Shan

Affiliations1. School of Medicine, South China University of Technology, Guangzhou, China; 2. Key Laboratory of Clinical Pharmacology Guangdong Provincial Health Commission, Medical Research Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China; 3. School of Basic Medical Sciences, Guangzhou National Laboratory, Guangzhou Medical University, Guangzhou, China; 4. Department of Biochemistry & Molecular Biology, Libin Cardiovascular Institute, The University of Calgary, Calgary, Canada; 5. Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China

Source PDF DOI Publisher page
235 days

Serum/glucocorticoid-regulated kinase 1 regulates vascular inflammation in atherosclerosis

AuthorsYang-xian Li; Shu-xiang Ding; Hui-ling Hong; Xiao-yun Cao; Yu-meng Han; Jin-wei Tian; Sin-hang Fung; Stephen Kwok-Wing Tsui; Ya-lan Wu; Xiao Yu Tian

Affiliations1. School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong SAR, China; 2. Department of Cardiology, Department of Geriatrics, The Second Affiliated Hospital of Harbin Medical University, Harbin, China; 3. Department of Histology and Embryology, School of Basic Medical Sciences, Central South University, Changsha, China

Source PDF DOI Publisher page
123 days

Time-resolved proteomic and phosphoproteomic analysis reveals convergent and divergent biological perturbations induced by FDA-approved CDK4/6 inhibitors in hormone receptor-positive breast cancers

AuthorsShi-yu Duan; Lin-hui Zhai; Wei Zhang; Luo-yi Chen; Rui-xi Zhao; Xun Zou; Jia-hui Ni; Xing-long Jia; Tian-yu Liu; Hang Fu; Min Huang; Min-jia Tan; Cheng-yu Chu; Yi-ting Jin

Affiliations1. Department of Thyroid and Breast Surgery, General Surgery, Huashan Hospital, Fudan University, Shanghai, China; 2. Translational Research Institute of Brain and Brain-like Intelligence, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai, China; 3. State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

Source PDF DOI Publisher page
223 days

Metabolic checkpoint blockade of IL4I1 by ZY-MY-111 reactivates CD8 + T cell immunity and suppresses tumor growth

AuthorsJu-fei Li; Hao Wang; Ling Kang; Cheng-cheng Xu; Yuan-chun Liu; Zi-xuan Li; Shao-hao Lin; Ming-zhi Wang; Xiao-min Xu; Pei-pei Wang; Wan-chao Yin; Yu-bo Zhou; Yu Zhou; Jia Li

Affiliations1. School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China; 2. Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, China; 3. Drug Discovery & Development Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China; 4. University of Chinese Academy of Sciences, Beijing, China; 5. School of Pharmacy, China Pharmaceutical University, Nanjing, China; 6. School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, China; 7. College of Life Science and Technology, Xinjiang University, Xinjiang, China; 8. School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, China; 9. Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China; 10. Center for Structure and Function of Drug Targets, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China; 11. The National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China; 12. State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China

Source PDF DOI Publisher page
86 days

ApoE impairs microglial efferocytosis by targeting Gas6/MerTK in a mouse model of acute seizure

AuthorsBo Gao; Si-min Cheng; Yu-yan Zhang; Hui-xia Yang; Ming-ming Hu; Yu Wang; Jian-ming Han; Li Yu; Shun-zhi Cao; Kun Dong; Hua Kong; Wen-ning Wu

Affiliations1. Department of Pharmacology, School of Pharmacy, Anhui Medical University, Hefei, China; 2. Department of Pharmacy, The Second People’s Hospital of Hefei, Hefei Hospital Affiliated to Anhui Medical University, Hefei, China; 3. Institute of Intelligent Machines, Chinese Academy of Science; University of Science and Technology of China, Hefei, China; 4. Publishing Center of Anhui Medical University, Hefei, China; 5. Department of Neurology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China

Source PDF DOI Publisher page
95 days

Echoes in the powerhouse: mito-lncRNAs contribution to cardiac function and disease

AuthorsAbdallah Iddy Chaurembo; Na Xing; Zi-feng Huang; Baraka Simon Mayamba; Francis Chanda; Yun-tao Liang; Yong-fang Lin; Wen-hui Deng; Jian-yuan Huang; Zeng-yu He; Zheng Tan; Chi Shu; Han-bin Lin

Affiliations1. Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, China; 2. State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China; 3. University of Chinese Academy of Sciences, Beijing, China; 4. School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China; 5. School of Pharmacy, State Key Laboratory of Quality Research in Chinese Medicine, Laboratory of Drug Discovery from Natural Resources and Industrialization, Macau University of Science and Technology, Macao SAR, China; 6. Guangdong Pharmaceutical University, Guangzhou, China; 7. Food Science College, Shenyang Agricultural University, Shenyang, China

Source PDF DOI Publisher page
142 days

Activation of peripheral muscarinic receptors rescues depressive-like behaviors via gut-brain-axis, involving parasympathetic excitation

AuthorsFang-fang Gao; Yi-fan Xu; Jing Zhang; Shi-meng Qu; Fan Xiao; Jin-qian Cheng; Zhuo-qin Yuan; Guang-ji Wang; Meng-jie Yu; Ji-ye Aa

Affiliations1. Jiangsu Provincial Key Laboratory of Drug Metabolism and Pharmacokinetics, State Key Laboratory of Natural Medicines, Research Unit of PK–PD Based Bioactive Components and Pharmacodynamic Target Discovery of Natural Medicine of Chinese Academy of Medical Sciences, China Pharmaceutical University, Nanjing, China; 2. School of Pharmacy, China Pharmaceutical University, Nanjing, China

Source PDF DOI Publisher page
80 days

The solute carrier transporter SLCO5A1 as a novel therapeutic target for the treatment of myocardial infarction-induced heart failure

AuthorsKe-yu Liu; Ke Gong; Fang Fang; Qing-hua Chen; Jin-rong Xu; Liang-qing Zhang; Wen-liang Chen

Affiliations1. Department of Anesthesiology, The Second Affiliated Hospital of Guangdong Medical University, Guangdong Medical University, Zhanjiang, China; 2. School of Obstetrics and Pediatrics, Guangdong Medical University, Zhanjiang, China; 3. Translational Medicine Center, The Second Affiliated Hospital of Guangdong Medical University, Guangdong Medical University, Zhanjiang, China; 4. Medical Interdisciplinary Science Research Center of Western Guangdong, The Second Affiliated Hospital of Guangdong Medical University, Guangdong Medical University, Zhanjiang, China; 5. Key Laboratory for Research on Organ Interactions in Major Diseases, The Second Affiliated Hospital of Guangdong Medical University, Guangdong Medical University, Zhanjiang, China; 6. Department of Cardiovascular Medicine, The Second Affiliated Hospital of Guangdong Medical University, Guangdong Medical University, Zhanjiang, China

Source PDF DOI Publisher page
202 days

Astrocytic adrenergic α2 receptor contributes to the mechanisms underlying the circadian rhythmicity of seizure susceptibility

AuthorsCong Wang; Ping-chuan Yuan; Qian Sun; Michael Lazarus; Wei-min Qu; Zhi-li Huang; Feng-fei Ding

Affiliations1. State Key Laboratory of Brain Function and Disorders, Institutes of Brain Science, MOE Frontiers Center for Brain Science; Joint International Research Laboratory of Sleep; Department of Pharmacology, School of Basic Medical Sciences, Fudan University, Shanghai, China; 2. Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, China; 3. International Institute for Integrative Sleep Medicine (WPI-IIIS), Doctoral Program in Neuroscience, University of Tsukuba, Tsukuba, Japan; 4. Tsukuba Institute for Advanced Research (TIAR) and Institute of Medicine, University of Tsukuba, Tsukuba, Japan

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.